STAA News and Press, STAAR Surgical Company From 02/23/24

2024-02-23 17:35:15 ET More on STAAR Surgical STAAR Surgical: Slowly Coming In My Sight STAAR Surgical collaborates with SharpeVision in the U.S. STAAR Surgical forecasts 2024 net sales between $335M - $340M Seeking Alpha’s Quant Rating on STAAR Surgic...

Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it will release financial results for the fourth quarter ending Decem...

2024-02-15 01:30:00 ET Summary Vision Capital is fundamental-driven, bottom-up, and only focuses on investing in long-only publicly-listed equities. For 2023, Vision Capital returned +69.9% versus the S&P 500’s +24.0%. A large majority of our holdings were sold off ...

2024-02-12 23:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-02 07:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-23 07:33:08 ET More on STAAR Surgical STAAR Surgical: Slowly Coming In My Sight STAAR Surgical Company (STAA) Q3 2023 Earnings Call Transcript STAAR Surgical forecasts 2024 net sales between $335M - $340M STAAR Surgical Q3 2023 Earnings Preview ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, and SharpeVision, a premier ophthalmology group with clinics in Seattle, Chicago and Austin, today...

2024-01-16 13:12:52 ET Summary RxSight reported preliminary Q4 results, capping off a record year for growth where sales climbed by approximately 82%. The company is capturing strong demand for its adjustable intraocular lens technology for cataract and lens replacement surgery. ...

2024-01-11 18:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...